Dashboard
1
Poor long term growth as Net Sales has grown by an annual rate of 3.44% and Operating profit at -2.14% over the last 5 years
2
The company has declared Positive results for the last 4 consecutive quarters
3
With ROE of 7.54%, it has a very expensive valuation with a 3.79 Price to Book Value
4
Market Beating performance in long term as well as near term
Stock DNA
Pharmaceuticals & Biotechnology
CNY 15,764 Million (Large Cap)
50.00
NA
1.08%
-0.19
7.54%
3.79
Revenue and Profits:
Net Sales:
624 Million
(Quarterly Results - Mar 2026)
Net Profit:
98 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
28.57%
0%
28.57%
6 Months
12.61%
0%
12.61%
1 Year
50.1%
0%
50.1%
2 Years
89.99%
0%
89.99%
3 Years
36.74%
0%
36.74%
4 Years
48.03%
0%
48.03%
5 Years
169.89%
0%
169.89%
Guangdong Zhongsheng Pharmaceutical Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
3.44%
EBIT Growth (5y)
-2.14%
EBIT to Interest (avg)
1.98
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.15
Sales to Capital Employed (avg)
0.51
Tax Ratio
15.28%
Dividend Payout Ratio
61.65%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
8.05%
ROE (avg)
6.83%
Valuation key factors
Factor
Value
P/E Ratio
50
Industry P/E
Price to Book Value
3.79
EV to EBIT
52.47
EV to EBITDA
39.34
EV to Capital Employed
4.46
EV to Sales
5.95
PEG Ratio
0.26
Dividend Yield
1.08%
ROCE (Latest)
8.51%
ROE (Latest)
7.54%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
624.20
634.00
-1.55%
Operating Profit (PBDIT) excl Other Income
109.10
43.30
151.96%
Interest
0.40
1.50
-73.33%
Exceptional Items
-13.20
-12.50
-5.60%
Consolidate Net Profit
98.00
21.20
362.26%
Operating Profit Margin (Excl OI)
174.70%
17.50%
15.72%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is -1.55% vs 7.64% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 362.26% vs -65.07% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
2,510.40
2,453.30
2.33%
Operating Profit (PBDIT) excl Other Income
410.80
327.40
25.47%
Interest
5.20
26.20
-80.15%
Exceptional Items
-37.10
-303.20
87.76%
Consolidate Net Profit
266.70
-374.00
171.31%
Operating Profit Margin (Excl OI)
113.50%
81.90%
3.16%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 2.33% vs -5.53% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 171.31% vs -249.66% in Dec 2024
About Guangdong Zhongsheng Pharmaceutical Co., Ltd. 
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






